Volatility
3 articles in this category
HealthcareTechnical AnalysisVolatility
Regencell Bioscience (RGC): Extreme Valuation and Mixed Signals Point to Near-Term Consolidation
Despite a massive $13B market cap and technical breakout chatter, RGC's zero revenue and neutral RSI suggest sideways trading as the market digests its ultra-low float volatility.
RGC
Read more